Interactions Between Buprenorphine and the Protease Inhibitors Darunavir-Ritonavir and Fosamprenavir-Ritonavir

Background. This study examined drug interactions between buprenorphine, a partial opioid agonist used for opioid dependence treatment and pain management, and the protease inhibitors (PIs) darunavir-ritonavir and fosamprenavir-ritonavir. Methods. The pharmacokinetics of buprenorphine and its metabo...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Gruber, Valerie A., Rainey, Petrie M., Moody, David E., Morse, Gene D., Ma, Qing, Prathikanti, Sudha, Pade, Patricia A., Alvanzo, Anika A. H., McCance-Katz, Elinore F.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2012
Onderwerpen:
HIV/AIDS
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3258270/
https://ncbi.nlm.nih.gov/pubmed/22100576
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cir799
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items